Search

everythinglearnresearchcommunity

for

Search:↓

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The normal human prostate does not significantly affect blood DHT levels.

Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

Diagnosing simple-virilizing congenital adrenal hyperplasia can be difficult and requires thorough testing and expert advice.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

High doses of certain vitamins can cause serious side effects and health risks.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Sensitive skin is often caused by nerve fibers and environmental factors, and can be managed with mild skincare and professional advice.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.